Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0392674 (
exhaustion
)
13,658
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We monitored expression of
PD-1
(a mediator of T-cell
exhaustion
and viral persistence) on hepatitis C virus (HCV)-specific CD8(+) and CD4(+) T cells from blood and liver during acute and chronic infections and after the resolved infection stage.
PD-1
expression on HCV-specific T cells was high early in acute infection irrespective of clinical outcome, and most cells continued to express
PD-1
in resolved and chronic stages of infection; intrahepatic expression levels were especially high. Our results suggest that an analysis of
PD-1
expression alone is not sufficient to predict infection outcome or to determine T-cell functionality in HCV infection.
...
PMID:High level of PD-1 expression on hepatitis C virus (HCV)-specific CD8+ and CD4+ T cells during acute HCV infection, irrespective of clinical outcome. 1816 Apr 39
Chronic viral infections pose serious health concerns, as secondary complications such as immunodeficiencies and cancers are common. Treating such infections with conventional vaccine approaches has proved to be difficult. Studies in animals and humans suggest that vaccine failure is probably due to
exhaustion
of antiviral T cell responses, which occurs in a number of chronic infections. Attempts to elucidate the causes of impairment of antiviral immunity have pointed to a role for the immunomodulatory cytokine IL-10 in the ability of viruses to establish persistence. Induction of IL-10 production by the host during chronic infection appears to be one of the viral means to alter the class of the antiviral immune response and induce generalized immune suppression. Recent work by us and others suggests that it is possible to resuscitate antiviral immunity by interfering with the IL-10 signalling pathway. Targeting IL-10 thus constitutes a promising alternative to conventional vaccine strategies which have not proved to be successful in treating chronic infections. In addition, sterile cure may be achieved with minimal side-effects by combining agents that alter the IL-10 signalling pathway with other compounds, such as antiviral drugs or interferon, but also agents neutralizing other crucial elements of T cell
exhaustion
, such as
PD-1
.
...
PMID:IL-10 and the resolution of infections. 1816 57
The phenotype and function of antigen-specific CD8 T cells are closely associated with the efficacy of a therapeutic vaccination. Here we showed that multiple immunizations with LCMV gp33-41 peptide (KAV) in Freund's adjuvant could induce KAV-specific CD8 T cells with low expression of CD127 and CD62L molecules. The inhibitory receptor
PD-1
was also expressed on a substantial part of KAV-specific CD8 T cells, and its expression level on KAV-specific CD8 T cells in spleen and lymph nodes was much higher when compared to those in peripheral blood. Furthermore, KAV-specific CD8 T cells could specifically kill KAV-pulsed target cells in vivo but the efficiency was low. These data suggest that prime-boost vaccination schedule with peptide in Freund's adjuvant can elicit antigen-specific CD8 T cells of effector-like phenotype with partial functional
exhaustion
, which may only provide short-term protection against the pathogen.
...
PMID:Phenotypic and functional analysis of LCMV gp33-41-specific CD8 T cells elicited by multiple peptide immunization in mice revealed the up-regulation of PD-1 expression on antigen-specific CD8 T cells. 1816 54
Recent data supports that increased expression of
PD-1
, a negative regulator of immune function, is associated with T cell
exhaustion
during chronic viral infection. However,
PD-1
expression during acute infection and vaccination has not been studied in great detail in primates. Here, we examine
PD-1
expression on CD3(+) T cells following DNA vaccination or lentiviral infection of macaques. Ex vivo peptide stimulation of PBMC from DNA-vaccinated uninfected macaques revealed a temporal increase in
PD-1
expression in proliferating antigen-specific CD8(+) T cells. Following the initial increase,
PD-1
expression steadily declined as proliferation continued, with a concomitant increase in IFN-gamma secretion. Subsequent examination of
PD-1
expression on T cells from uninfected and lentivirus-infected non-vaccinated macaques revealed a significant increase in
PD-1
expression with lentiviral infection, consistent with previous reports.
PD-1
expression was highest on cells with activated memory and effector phenotypes. Despite their decreased telomere length,
PD-1
(hi) T cell populations do not appear to have statistically significant uncapped telomeres, typically indicative of proliferative
exhaustion
, suggesting a different mechanistic regulation of proliferation by
PD-1
. Our data indicate that
PD-1
expression is increased as a result of T cell activation during a primary immune response as well as during persistent immune activation in macaques.
...
PMID:Activation drives PD-1 expression during vaccine-specific proliferation and following lentiviral infection in macaques. 1838 75
Cytomegalovirus (CMV) represents a major cause of infectious complications after transplantation. Recently, chronic infections with lymphocyte choriomeningitis virus (LCMV), HIV or HCV were shown to be associated with functionally exhausted T cells characterized by high expression of the programmed death (PD)-1 molecule and altered cytokine expression patterns. We therefore hypothesized that functional
exhaustion
of CMV-specific CD4 T cells may determine impaired CMV control in patients after renal transplantation. In viremic transplant recipients, a significantly higher proportion of CMV-specific CD4 T cells was
PD-1
positive (median 40.9%, 17.0-88.7%) as compared to nonviremic transplant patients (8.8%, 0.8-80.5%), dialysis patients (8.8%, 0-36.7%) or controls (3.2%, 0.3-15.4%, p < 0.0001). In line with functional impairment,
PD-1
-positive T cells produced significantly less IFNgamma as compared to
PD-1
-negative T cells (p < 0.0001). Moreover, unlike controls or nonviremic patients, CMV-specific T cells from viremic patients showed a significant loss of IL-2 production (p < 0.0001). Interestingly, functional anergy of CMV-specific CD4 T cells was reversible in that antibody-mediated blockade of
PD-1
signaling with its ligands PD-L1/-L2 led to an up to 10-fold increase in CMV-specific proliferation. In conclusion, expression of
PD-1
defines a reversible defect of CMV-specific CD4 T cells that is associated with viremia, and blocking
PD-1
signaling may provide a potential target for enhancing the function of exhausted T cells in chronic CMV infection.
...
PMID:PD-1 expression and IL-2 loss of cytomegalovirus- specific T cells correlates with viremia and reversible functional anergy. 1851 Jun 28
Exhaustion
of virus-specific T cells may play an important role in the pathophysiology of chronic viral infections. Here, we analyzed telomere length and telomerase activity in HIV-1-specific CD8+ T cells from progressors or controllers to determine underlying molecular pathways of T-cell
exhaustion
and senescence. Telomere lengths of HIV-1-specific CD8+ T cells from progressors were significantly shorter compared with autologous cytomegalovirus (CMV)/Epstein-Barr virus (EBV)-specific CD8+ T cells or bulk CD8+ T cells, while telomere lengths from controllers significantly exceeded those of autologous bulk CD8+ T cells and reached a similar level as HIV-1-specific CD8+ T cells collected during primary HIV-1 infection. Telomere length stabilization in controllers corresponded to high levels of constitutive telomerase activity, which was associated with preservation of cytotoxic and proliferative properties. Conversely, limited constitutive telomerase activity was observed in HIV-1-specific CD8+ T cells from progressors, although an increase in both telomere length and telomerase activity was achieved in antigenic-peptide-stimulated cells from progressors after blocking the
PD-1
/PD ligand 1 (PD-L1) pathway. Collectively, these data suggest a causal role of telomere shortening for the functional deficiencies of HIV-1-specific CD8+ T cells in chronic progressive infection, while high constitutive telomerase activities appears to contribute to maintenance of polyfunctional HIV-1-specific CD8+ T cells from HIV-1 controllers.
...
PMID:Telomerase activity of HIV-1-specific CD8+ T cells: constitutive up-regulation in controllers and selective increase by blockade of PD ligand 1 in progressors. 1872 48
PD-1
is a transmembrane protein involved in the regulation of immunological tolerance. Multiple studies have reported an association between high levels of
PD-1
expressed on T cell surfaces and
exhaustion
in lymphocyte populations when challenged by chronic viral infections, such as HIV. By using model systems consisting of murine EL4 cells, which constitutively express
PD-1
, and primary murine CD8 T cells that express
PD-1
upon T cell stimulation, we have identified two tissue-specific hypersensitive sites at the 5' CR of the
PD-1
locus. Gene reporter assays in CD8 T cells have shown that one of these sites has robust transcriptional activity in response to cell stimulation. Cell treatment with the calcineurin inhibitor cyclosporine A or a NFAT-specific inhibitor led to a sharp reduction in
PD-1
expression in the constitutive and inducible systems. Furthermore, analysis of this region by chromatin immunoprecipitation assay revealed NFATc1 binding associated with gene activation in EL4 and primary CD8 T cells. Mutation of the NFATc1 binding site in
PD-1
reporter constructs resulted in a complete loss of promoter activity. Together, these results demonstrate that
PD-1
gene regulation occurs in part via the recruitment of NFATc1 to a novel regulatory element at the pdcd1 locus and provides the molecular mechanism responsible for the induction of
PD-1
in response to T cell stimulation.
...
PMID:NFATc1 regulates PD-1 expression upon T cell activation. 1880 87
Adult T-cell leukemia/lymphoma (ATLL) develops after infection with human T-cell leukemia virus-1 (HTLV-1) after a long latency period. The negative regulatory programmed death-1/programmed death-1 ligand 1 (
PD-1
/PD-L1) pathway has been implicated in the induction of cytotoxic T-lymphocyte (CTL)
exhaustion
during chronic viral infection along with tumor escape from host immunity. To determine whether the
PD-1
/PD-L1 pathway could be involved in the establishment of persistent HTLV-1 infections and immune evasion of ATLL cells in patients, we examined
PD-1
/PD-L1 expression on cells from 27 asymptomatic HTLV-1 carriers (ACs) and 27 ATLL patients in comparison with cells from 18 healthy donors.
PD-1
expression on HTLV-1-specific CTLs from ACs and ATLL patients was dramatically elevated. In addition,
PD-1
expression was significantly higher on CD8+ T cells along with cytomegalovirus (CMV)- and Epstein-Barr virus (EBV)-specific CTLs in ATLL patients compared with ACs and control individuals. Primary ATLL cells in 21.7% of ATLL patients expressed PD-L1, whereas elevated expression was not observed in cells from ACs. Finally, in functional studies, we observed that an anti-PD-L1 antagonistic antibody upregulated HTLV-1-specific CD8+T-cell response. These observations suggest that the
PD-1
/PD-L1 pathway plays a role in fostering persistent HTLV-1 infections, which may further ATLL development and facilitate immune evasion by ATLL cells.
...
PMID:PD-1/PD-L1 expression in human T-cell leukemia virus type 1 carriers and adult T-cell leukemia/lymphoma patients. 1883 Feb 59
Exhaustion
of T cell responses during chronic viral infections has been observed in both mouse and man and has been attributed to up-regulation of
PD-1
on the surface of exhausted T cells. In patients with chronic human HIV infection, T cell
exhaustion
leads to opportunistic infections associated with AIDS. However, not all the exhausted T cells express
PD-1
, suggesting that other molecules may be involved in the phenotype. A new study now demonstrates a central role for T cell immunoglobulin and mucin domain-containing protein-3 (TIM-3) in T cell
exhaustion
during chronic HIV infection and suggests that TIM-3 may be a novel therapeutic target in chronic viral diseases.
...
PMID:TIMs: central regulators of immune responses. 1900 Nov 39
T cell
exhaustion
often occurs during chronic infection and prevents optimal viral control. The molecular pathways involved in T cell
exhaustion
remain poorly understood. Here we show that exhausted CD8+ T cells are subject to complex layers of negative regulation resulting from the coexpression of multiple inhibitory receptors.
Exhausted
CD8+ T cells expressed up to seven inhibitory receptors. Coexpression of multiple distinct inhibitory receptors was associated with greater T cell
exhaustion
and more severe infection. Regulation of T cell
exhaustion
by various inhibitory pathways was nonredundant, as blockade of the T cell inhibitory receptors
PD-1
and LAG-3 simultaneously and synergistically improved T cell responses and diminished viral load in vivo. Thus, CD8+ T cell responses during chronic viral infections are regulated by complex patterns of coexpressed inhibitory receptors.
...
PMID:Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. 1904 18
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>